Terbinafine Tablet
Product Images NDC 71205-152

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Terbinafine (NDC 71205-152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-152-30 (250mg 30tabs)

Label for Terbinafine 250 mg oral tablets by Proficient Rx LP. The package contains 30 tablets. Each white, round, flat-faced tablet with beveled edges is debossed with 'IG' on one side and '209' on the other. Manufacturer is InvaGen Pharmaceuticals, Inc. Storage instructions and multiple codes are also displayed.*

FDA Label Image

Image 2 (Terbinafine Str)

Chemical structure of terbinafine hydrochloride, depicting the molecular arrangement of the active ingredient terbinafine with a hydrochloride component.*

FDA Label Image

Image 1 (Terbinafine Table)

A data table comparing adverse events and discontinuation rates between Terbinafine Tablets and placebo. It lists percentages for events such as headache, gastrointestinal symptoms (diarrhea, dyspepsia, abdominal pain, nausea, flatulence), dermatological symptoms (rash, pruritus, urticaria), liver enzyme abnormalities, taste disturbance, and visual disturbance among treated and placebo groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.